Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of Cancer

Author's Avatar
Feb 11, 2021
Article's Main Image

Molecular Templates to receive $70 million upfront payment with potential for additional milestone and royalty payments on future sales